Launching of a first-in-class drug that could cause positive market disruption
Our client, a top-3 pharmaceutical company, was planning for the future launch of a new class of drug that would bring positive disruption to an established therapy area.
Real-time HCP tracking insights and unique data
Using CREATION Pinpoint, our online HCP insights service, we studied 39,000 HCP posts from 8,000 HCPs on public and HCP-only social media channels, in five markets across a 12 month period. We developed unique HCP insights regarding the burden and impact of disease, identified Digital Opinion Leaders, and analysed HCP digital behaviours in the therapy area.
The client implemented content strategies aimed at specific customer personas
Using our insights, the client was able to: